Small interfering RNA for cancer treatment: overcoming hurdles in delivery

Rao, 2009, siRNA vs. shRNA: similarities and differences, Adv Drug Deliv Rev, 61, 746, 10.1016/j.addr.2009.04.004

Tabernero, 2013, First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement, Canc Discov, 3, 406, 10.1158/2159-8290.CD-12-0429

Tang, 2005, siRNA and miRNA: an insight into RISCs, Trends Biochem Sci, 30, 106, 10.1016/j.tibs.2004.12.007

Li, 2012, Molecular mechanisms of RNA-triggered gene silencing machineries, Acc Chem Res, 45, 1122, 10.1021/ar200253u

Nykänen, 2001, ATP requirements and small interfering RNA structure in the RNA interference pathway, Cell, 107, 309, 10.1016/S0092-8674(01)00547-5

Hutvágner, 2002, A microRNA in a multiple-turnover RNAi enzyme complex, Science, 297, 2056, 10.1126/science.1073827

Oh, 2009, siRNA delivery systems for cancer treatment, Adv Drug Deliv Rev, 61, 850, 10.1016/j.addr.2009.04.018

Elbashir, 2001, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 411, 494, 10.1038/35078107

Soutschek, 2004, Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs, Nature, 432, 173, 10.1038/nature03121

de Fougerolles, 2007, Interfering with disease: a progress report on siRNA-based therapeutics, Nat Rev Drug Discov, 6, 443, 10.1038/nrd2310

Ye, 2012, Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax, Oncol Lett, 3, 879

Bai, 2012, Sensitization of breast cancer cells to taxol by inhibition of taxol resistance gene 1, Oncol Lett, 3, 135, 10.3892/ol.2011.416

Schiffelers, 2004, Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle, Nucleic Acids Res, 32, 1, 10.1093/nar/gnh140

Perez, 2011, Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines, Anticancer Res, 31, 2813

Yamazaki, 2015, SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells, Vet J, 204, 60, 10.1016/j.tvjl.2015.02.009

Liu, 2009, SiRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity, Dig Dis Sci, 54, 89, 10.1007/s10620-008-0329-4

Jafarlou, 2018, Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia, Artif Cells, Nanomed Biotechnol, 46, 1792

Duxbury, 2004, RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine, Oncogene, 23, 1539, 10.1038/sj.onc.1207272

Schmitz, 2004, Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds, Canc Res, 64, 1431, 10.1158/0008-5472.CAN-03-1203

Chung, 2015, Downregulation of vascular endothelial growth factor enhances chemosensitivity by induction of apoptosis in hepatocellular carcinoma cells, Cell J, 17, 273

Liu, 2018, RBFOX3 regulates the chemosensitivity of cancer cells to 5-fluorouracil via the PI3K/AKT, EMT and cytochrome-c/caspase pathways, Cell Physiol Biochem, 46, 1365, 10.1159/000489153

Duxbury, 2004, siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity, J Am Coll Surg, 198, 953, 10.1016/j.jamcollsurg.2004.01.037

Nozawa, 2006, Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma, Canc Sci, 97, 1115, 10.1111/j.1349-7006.2006.00287.x

Wang, 2007, Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregulation of stathmin expression, Mol Med, 13, 567, 10.2119/2007-00046.Wang

Liu, 2009, Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel, J Control Release, 140, 277, 10.1016/j.jconrel.2009.08.013

Shen, 2009, Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity, Acta Biochim Biophys Sin (Shanghai), 41, 223, 10.1093/abbs/gmp005

Kim, 2018, Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells, Biomed Pharmacother, 108, 584, 10.1016/j.biopha.2018.09.041

Yue, 2014, Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells—an in vitro study, Eur Rev Med Pharmacol Sci, 18, 1735

Zhang, 2014, Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin, World J Gastroenterol, 20, 8229, 10.3748/wjg.v20.i25.8229

Zheng, 2018, siRNA knockdown of RRM2 effectively suppressed pancreatic tumor growth alone or synergistically with doxorubicin, Mol Ther Nucleic Acids, 12, 805, 10.1016/j.omtn.2018.08.003

Yang, 2008, The effect of HIF-1α siRNA on growth and chemosensitivity of Mia-paca cell line, Yonsei Med J, 49, 295, 10.3349/ymj.2008.49.2.295

Shervington, 2008, Silencing DNA methyltransferase (DNMT) enhances glioma chemosensitivity, Oligonucleotides, 18, 365, 10.1089/oli.2008.0128

Zhang, 2015, Blockage of tropomyosin receptor kinase a (TrkA) enhances chemo-sensitivity in breast cancer cells and inhibits metastasis in vivo, Int J Clin Exp Med, 8, 634

Wang, 2018, Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling, Biol Res, 51, 1, 10.1186/s40659-018-0205-4

Yu, 2008, RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells, J Cell Mol Med, 12, 2334, 10.1111/j.1582-4934.2008.00257.x

Li, 2018, Bioengineered NRF2‒siRNA is effective to interfere with NRF2 pathways and improve chemosensitivity of human cancer cells, Drug Metab Dispos, 46, 2, 10.1124/dmd.117.078741

Liu, 2013, siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells, Oncol Rep, 29, 1183, 10.3892/or.2012.2196

Li, 2018, Effect of AQP-5 silencing by siRNA interference on chemosensitivity of breast cancer cells, OncoTargets Ther, 11, 3359, 10.2147/OTT.S160313

Guo, 2015, Down-regulation of survivin expression by siRNA suppresses proliferation and enhances chemosensitivity in human pancreatic cancer cell line Panc-1, 400

Shen, 2014, Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR, Biomaterials, 35, 8621, 10.1016/j.biomaterials.2014.06.035

Yang, 2008, Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells, J Int Med Res, 36, 734, 10.1177/147323000803600416

Ide, 2012, Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma, BMC Canc, 12, 420, 10.1186/1471-2407-12-420

Radia, 2013, Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines, Int J Mol Sci, 14, 7959, 10.3390/ijms14047959

Morgan-Lappe, 2006, RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors, Oncogene, 25, 1340, 10.1038/sj.onc.1209169

Aza-Blanc, 2003, Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening, Mol Cell, 12, 627, 10.1016/S1097-2765(03)00348-4

MacKeigan, 2005, Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance, Nat Cell Biol, 7, 591, 10.1038/ncb1258

Futami, 2005, Identification of a network involved in thapsigargin-induced apoptosis using a library of small interfering RNA expression vectors, J Biol Chem, 280, 826, 10.1074/jbc.M409948200

Brummelkamp, 2003, Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB, Nature, 424, 797, 10.1038/nature01811

Berns, 2004, A large-scale RNAi screen in human cells identifies new components of the p53 pathway, Nature, 428, 431, 10.1038/nature02371

Kittler, 2004, An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division, Nature, 432, 1036, 10.1038/nature03159

Song, 2004, Crystal structure of argonaute and its implications for RISC slicer activity, Science, 305, 1434, 10.1126/science.1102514

Chiu, 2003, siRNA function in RNAi: a chemical modification analysis, RNA, 9, 1034, 10.1261/rna.5103703

Li, 2014, Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas, Biomaterials, 35, 3840, 10.1016/j.biomaterials.2014.01.019

Xu, 2015, Delivery systems for siRNA drug development in cancer therapy, Asian J Pharm Sci, 10, 1, 10.1016/j.ajps.2014.08.011

Bangham, 1964, Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope, J Mol Biol, 8, 660, 10.1016/S0022-2836(64)80115-7

Tagami, 2009, Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production, J Control Release, 137, 234, 10.1016/j.jconrel.2009.04.006

Felgner, 1987, Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure, Proc Natl Acad Sci U S A, 84, 7413, 10.1073/pnas.84.21.7413

Omidi, 2003, Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells, J Drug Target, 11, 311, 10.1080/10611860310001636908

Yu, 2004, Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide, Nucleic Acids Res, 32, 1, 10.1093/nar/gnh049

Pirollo, 2006, Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery, Hum Gene Ther, 17, 117, 10.1089/hum.2006.17.117

Lin, 2014, Lipid-based nanoparticles in the systemic delivery of siRNA, Nanomedicine, 9, 105, 10.2217/nnm.13.192

Kedmi, 2010, The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation, Biomaterials, 31, 6867, 10.1016/j.biomaterials.2010.05.027

Wasungu, 2006, Cationic lipids, lipoplexes and intracellular delivery of genes, J Control Release, 116, 255, 10.1016/j.jconrel.2006.06.024

Li, 2008, Tumor-targeted delivery of siRNA by self-assembled nanoparticles, Mol Ther, 16, 163, 10.1038/sj.mt.6300323

Santel, 2006, A novel siRNA–lipoplex technology for RNA interference in the mouse vascular endothelium, Gene Ther, 13, 1222, 10.1038/sj.gt.3302777

Dana, 2017, Molecular mechanisms and biological functions of siRNA, Int J Biomed Sci, 13, 48, 10.59566/IJBS.2017.13048

Wu, 2014, 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity, Nat Commun, 5, 1

Gomes-Da-Silva, 2012, Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges, Acc Chem Res, 45, 1163, 10.1021/ar300048p

Buyens, 2012, Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design, J Control Release, 158, 362, 10.1016/j.jconrel.2011.10.009

Yagi, 2009, A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo, Canc Res, 69, 6531, 10.1158/0008-5472.CAN-08-3945

Carmona, 2009, Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles, Mol Pharm, 6, 706, 10.1021/mp800157x

Hatakeyama, 2011, Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG–lipid, Biomaterials, 32, 4306, 10.1016/j.biomaterials.2011.02.045

Chono, 2008, An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor, J Control Release, 131, 64, 10.1016/j.jconrel.2008.07.006

Yang, 2012, Single-step assembly of cationic lipid–polymer hybrid nanoparticles for systemic delivery of siRNA, ACS Nano, 6, 4955, 10.1021/nn300500u

Zhang, 2010, DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery, Int J Pharm, 390, 198, 10.1016/j.ijpharm.2010.01.035

Morrissey, 2005, Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs, Nat Biotechnol, 23, 1002, 10.1038/nbt1122

Zimmermann, 2006, RNAi-mediated gene silencing in non-human primates, Nature, 441, 111, 10.1038/nature04688

Judge, 2009, Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice, J Clin Invest, 119, 661, 10.1172/JCI37515

De Antonellis, 2013, MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines, Naunyn Schmiedebergs Arch Pharmacol, 386, 287, 10.1007/s00210-013-0837-4

Geisbert, 2010, Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study, Lancet, 375, 1896, 10.1016/S0140-6736(10)60357-1

He, 2014, Discovery of siRNA lipid nanoparticles to transfect suspension leukemia cells and provide in vivo delivery capability, Mol Ther, 22, 359, 10.1038/mt.2013.210

Jia, 2018, PPB Peptide-mediated siRNA-loaded stable nucleic acid lipid nanoparticles on targeting therapy of hepatic fibrosis, Mol Pharm, 15, 53, 10.1021/acs.molpharmaceut.7b00709

Mills, 2019, p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts, Sci Rep, 9, 1, 10.1038/s41598-019-41122-3

Aleku, 2008, Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression, Canc Res, 68, 9788, 10.1158/0008-5472.CAN-08-2428

Heidel, 2012, Cyclodextrin-containing polymers: versatile platforms of drug delivery materials, J Drug Deliv, 2012, 1, 10.1155/2012/262731

Davis, 2004, Cyclodextrin-based pharmaceutics: past, present and future, Nat Rev Drug Discov, 3, 1023, 10.1038/nrd1576

Stella, 1999, Mechanisms of drug release from cyclodextrin complexes, Adv Drug Deliv Rev, 36, 3, 10.1016/S0169-409X(98)00052-0

Freeman, 1996, The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs, Pharm Res, 13, 202, 10.1023/A:1016078728202

Gonzalez, 1999, New class of polymers for the delivery of macromolecular therapeutics, Bioconjugate Chem, 10, 1068, 10.1021/bc990072j

Suzie, 2002, Development of a nonviral gene delivery vehicle for systemic application, Bioconjugate Chem, 13, 630, 10.1021/bc0155768

Hu-Lieskovan, 2005, Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma, Canc Res, 65, 8984, 10.1158/0008-5472.CAN-05-0565

Bellocq, 2003, Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery, Bioconjugate Chem, 14, 1122, 10.1021/bc034125f

Mellet, 2011, Cyclodextrin-based gene delivery systems, Chem Soc Rev, 40, 1586, 10.1039/C0CS00019A

Heidel, 2007, Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA, Proc Natl Acad Sci U S A, 104, 5715, 10.1073/pnas.0701458104

Nabel, 1993, Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans, Proc Natl Acad Sci U S A, 90, 11307, 10.1073/pnas.90.23.11307

Caplen, 1995, Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis, Nat Med, 1, 39, 10.1038/nm0195-39

Farhood, 1995, The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer, Biochim Biophys Acta, 1235, 289, 10.1016/0005-2736(95)80016-9

Maitani, 2007, Cationic liposome (DC-Chol/DOPE = 1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression, Int J Pharm, 342, 33, 10.1016/j.ijpharm.2007.04.035

Dass, 2006, Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability, J Control Release, 113, 155, 10.1016/j.jconrel.2006.04.009

Oupicky, 2002, Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation, Mol Ther, 5, 463, 10.1006/mthe.2002.0568

Lee, 2018, PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery carrier for ovarian cancer therapy, Biochem Biophys Res Commun, 503, 1716, 10.1016/j.bbrc.2018.07.104

Liu, 2011, Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents, Canc Res, 71, 2240, 10.1158/0008-5472.CAN-10-1375

Seraj, 2019, Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: long-term silencing and anticancer effects in vivo, Biochem Pharmacol, 166, 192, 10.1016/j.bcp.2019.05.021

Tseng, 2007, Using disaccharides to enhance in vitro and in vivo transgene expression mediated by a lipid-based gene delivery system, J Gene Med, 9, 659, 10.1002/jgm.1063

Yang, 2013, Comprehensive study of cationic liposomes composed of DC-Chol and cholesterol with different mole ratios for gene transfection, Colloids Surf B Biointerfaces, 101, 6, 10.1016/j.colsurfb.2012.05.032

Bennett, 1995, Cholesterol enhances cationic liposome-mediated DNA transfection of human respiratory epithelial cells, Biosci Rep, 15, 47, 10.1007/BF01200214

Chen, 2013, Complexes containing cationic and anionic pH-sensitive liposomes: comparative study of factors influencing plasmid DNA gene delivery to tumors, Int J Nanomed, 8, 1573

Nchinda, 2002, Characterization of cationic lipid DNA transfection complexes differing in susceptibility to serum inhibition, BMC Biotechnol, 2, 1, 10.1186/1472-6750-2-12

Kisoon, 2002, A novel cationic cholesterol derivative, its formulation into liposomes, and the efficient transfection of the transformed human cell lines HepG2 and HeLa, Drug Deliv J Deliv Target Ther Agents, 9, 161

Hattori, 2019, Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex, J Drug Target, 27, 217, 10.1080/1061186X.2018.1502775

Lechanteur, 2018, Cationic liposomes carrying siRNA: impact of lipid composition on physicochemical properties, cytotoxicity and endosomal escape, Nanomaterials, 8, 1, 10.3390/nano8050270

Lechanteur, 2016, PEGylation of lipoplexes: the right balance between cytotoxicity and siRNA effectiveness, Eur J Pharmaceut Sci, 93, 493, 10.1016/j.ejps.2016.08.058

Behr, 1989, Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA, Proc Natl Acad Sci U S A, 86, 6982, 10.1073/pnas.86.18.6982

San, 1993, Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy, Hum Gene Ther, 4, 781, 10.1089/hum.1993.4.6-781

Wagner, 1991, Transferrin‒polycation‒DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells, Proc Natl Acad Sci U S A, 88, 4255, 10.1073/pnas.88.10.4255

Gao, 1996, Potentiation of cationic liposome-mediated gene delivery by polycations, Biochemistry, 35, 1027, 10.1021/bi952436a

Gao, 2013, Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA, Biomaterials, 34, 10084, 10.1016/j.biomaterials.2013.08.088

Li, 2008, Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA, Mol Ther, 16, 942, 10.1038/mt.2008.51

Li, 2006, Surface-modified LPD nanoparticles for tumor targeting, Ann N Y Acad Sci, 1082, 1, 10.1196/annals.1348.001

Chen, 2008, Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy, Expet Opin Drug Deliv, 5, 1301, 10.1517/17425240802568505

Chen, 2010, Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy, Mol Ther, 18, 828, 10.1038/mt.2009.291

Chen, 2010, Targeted nanoparticles deliver siRNA to melanoma, J Invest Dermatol, 130, 2790, 10.1038/jid.2010.222

Deng, 2013, Comparison of anti-EGFR-Fab’ conjugated immunoliposomes modified with two different conjugation linkers for siRNA delivery in SMMC-7721 cells, Int J Nanomed, 8, 3271, 10.2147/IJN.S47597

Chen, 2009, Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells, Mol Pharm, 6, 696, 10.1021/mp800136v

Li, 2019, SiRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo, Drug Des Dev Ther, 13, 757, 10.2147/DDDT.S180836

Hu, 2016, Liposome-protamine-DNA nanoparticle-mediated delivery of short hairpin RNA targeting brachyury inhibits chordoma cell growth, J Biomed Nanotechnol, 12, 1952, 10.1166/jbn.2016.2236

Jalali, 2012, Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles, Nanomed Nanotechnol Biol Med, 8, 692, 10.1016/j.nano.2011.09.010

Zhao, 2016, PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery, Nat Commun, 7, 1, 10.1038/ncomms11822

Gao, 2011, The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes, Biomaterials, 32, 3459, 10.1016/j.biomaterials.2011.01.034

Li, 2010, Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery, J Control Release, 142, 416, 10.1016/j.jconrel.2009.11.008

Huang, 2018, Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery, J Drug Target, 26, 398, 10.1080/1061186X.2017.1419360

Maitra, 2005, Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy, Expert Rev Mol Diagn, 5, 893, 10.1586/14737159.5.6.893

Sokolova, 2006, Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles, Biomaterials, 27, 3147, 10.1016/j.biomaterials.2005.12.030

Liu, 2005, Calcium phosphate nanoparticles as a novel nonviral vector for efficient transfection of DNA in cancer gene therapy, Cancer Biother Radiopharm, 20, 141, 10.1089/cbr.2005.20.141

Zhou, 2010, Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery, Int J Pharm, 392, 201, 10.1016/j.ijpharm.2010.03.012

Wang, 2017, Designed Synthesis of lipid-coated polyacrylic acid/calcium phosphate nanoparticles as dual pH-responsive drug-delivery vehicles for cancer chemotherapy, Chem Eur J, 23, 6586, 10.1002/chem.201700060

Tseng, 2014, Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases, Biomaterials, 35, 4688, 10.1016/j.biomaterials.2014.02.030

Wang, 2010, Targeting nanoparticles to cancer, Pharmacol Res, 62, 90, 10.1016/j.phrs.2010.03.005

Lee, 2013, Nano-sized CT contrast agents, Adv Mater, 25, 2641, 10.1002/adma.201300081

Curry, 2014, Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermal therapy, Contrast Media Mol Imaging, 9, 53, 10.1002/cmmi.1563

Goldman, 2007, Principles of CT: radiation dose and image quality, J Nucl Med Technol, 35, 213, 10.2967/jnmt.106.037846

Zhu, 2013, Stimulus-responsive nanopreparations for tumor targeting, Integr Biol, 5, 96, 10.1039/c2ib20135f

Kreuter, 1996, Nanoparticles and microparticles for drug and vaccine delivery, J Anat, 189, 503

Amendola, 2017, Surface plasmon resonance in gold nanoparticles: a review, J Phys Condens Matter, 29, 1, 10.1088/1361-648X/aa60f3

Kong, 2017, Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications, Molecules, 22, 1, 10.3390/molecules22091445

Prusty, 2018, Nano silver decorated polyacrylamide/dextran nanohydrogels hybrid composites for drug delivery applications, Mater Sci Eng C, 85, 130, 10.1016/j.msec.2017.11.028

Jain, 2005, Iron oxide nanoparticles for sustained delivery of anticancer agents, Mol Pharm, 2, 194, 10.1021/mp0500014

Ngamcherdtrakul, 2015, Cationic polymer modified mesoporous silica nanoparticles for targeted siRNA delivery to HER2+ breast cancer, Adv Funct Mater, 25, 2646, 10.1002/adfm.201404629

Lee, 2009, Gold, poly(β-amino ester) nanoparticles for small interfering RNA delivery, Nano Lett, 9, 2402, 10.1021/nl9009793

Kango, 2013, Surface modification of inorganic nanoparticles for development of organic-inorganic nanocomposites—a review, Prog Polym Sci, 38, 1232, 10.1016/j.progpolymsci.2013.02.003

Sperling, 2010, Surface modification, functionalization and bioconjugation of colloidal Inorganic nanoparticles, Philos Trans R Soc A Math Phys Eng Sci, 368, 1333, 10.1098/rsta.2009.0273

Roca, 2008, Probing cells with noble metal nanoparticle aggregates, Nanomedicine, 3, 555, 10.2217/17435889.3.4.555

Vilela, 2012, Sensing colorimetric approaches based on gold and silver nanoparticles aggregation: chemical creativity behind the assay. A review, Anal Chim Acta, 751, 24, 10.1016/j.aca.2012.08.043

Ding, 2014, Gold nanoparticles for nucleic acid delivery, Mol Ther, 22, 1075, 10.1038/mt.2014.30

Rosi, 2006, Oligonucleotide-modified gold nanoparticles for intracellular gene regulation, Science, 312, 1027, 10.1126/science.1125559

Seferos, 2009, Polyvalent DNA nanoparticle conjugates stabilize nucleic acids, Nano Lett, 9, 308, 10.1021/nl802958f

Jin, 2003, What controls the melting properties of DNA-linked gold nanoparticle assemblies?, J Am Chem Soc, 125, 1643, 10.1021/ja021096v

Lytton-Jean, 2005, A thermodynamic investigation into the binding properties of DNA functionalized gold nanoparticle probes and molecular fluorophore probes, J Am Chem Soc, 127, 12754, 10.1021/ja052255o

Thaxton, 2005, A bio-bar-code assay based upon dithiothreitol-induced oligonucleotide release, Anal Chem, 77, 8174, 10.1021/ac0514265

Giljohann, 2007, Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles, Nano Lett, 7, 3818, 10.1021/nl072471q

Hurst, 2006, Maximizing DNA loading on a range of gold nanoparticle sizes, Anal Chem, 78, 8313, 10.1021/ac0613582

Lee, 2008, Thermodynamically controlled separation of polyvalent 2-nm gold nanoparticle-oligonucleotide conjugates, J Am Chem Soc, 130, 5430, 10.1021/ja800797h

Giljohann, 2010, Gold nanoparticles for biology and medicine, Angew Chem Int Ed, 49, 3280, 10.1002/anie.200904359

Patel, 2010, Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles, Bioconjugate Chem, 21, 2250, 10.1021/bc1002423

Zani, 2015, Scavenger receptor structure and function in health and disease, Cells, 4, 178, 10.3390/cells4020178

Zhang, 2012, Antibody-linked spherical nucleic acids for cellular targeting, J Am Chem Soc, 134, 16488, 10.1021/ja306854d

Hao, 2011, Nucleic acid-gold nanoparticle conjugates as mimics of microRNA, Small, 7, 3158, 10.1002/smll.201101018

Oishi, 2006, Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing, Chem Lett, 35, 1046, 10.1246/cl.2006.1046

Giljohann, 2009, Gene regulation with polyvalent siRNA-nanoparticle conjugates, J Am Chem Soc, 131, 2072, 10.1021/ja808719p

Zheng, 2012, Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation, Proc Natl Acad Sci U S A, 109, 11975, 10.1073/pnas.1118425109

Massich, 2009, Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates, Mol Pharm, 6, 1934, 10.1021/mp900172m

Cheung, 2010, DNA and carbon nanotubes as medicine, Adv Drug Deliv Rev, 62, 633, 10.1016/j.addr.2010.03.007

Qi, 2008, Quantum dot—amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA, ACS Nano, 2, 1403, 10.1021/nn800280r

Boisselier, 2009, Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity, Chem Soc Rev, 38, 1759, 10.1039/b806051g

Kim, 2012, Dendronized gold nanoparticles for siRNA delivery, Small, 8, 3253, 10.1002/smll.201201141

Fitzgerald, 2016, Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer—synthesis, physicochemical characterisation and in vitro evaluation, J Mater Chem B, 4, 2242, 10.1039/C6TB00082G

Ahwazi, 2020, Immobilization of HIV-1 TAT peptide on gold nanoparticles: a feasible approach for siRNA delivery, J Cell Physiol, 235, 2049, 10.1002/jcp.29105

Shirazi, 2014, Cyclic peptide-capped gold nanoparticles for enhanced siRNA delivery, Molecules, 19, 13319, 10.3390/molecules190913319

Paul, 2014, Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro, J Gen Virol, 95, 1712, 10.1099/vir.0.066084-0

Yin, 2014, Non-viral vectors for gene-based therapy, Nat Rev Genet, 15, 541, 10.1038/nrg3763

Jensen, 2013, Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma, Sci Transl Med, 5, 1, 10.1126/scitranslmed.3006839

Huang, 2015, Light-activated RNA interference in human embryonic stem cells, Biomaterials, 63, 70, 10.1016/j.biomaterials.2015.06.006

Jiang, 2016, Progress and perspective of inorganic nanoparticle-based siRNA delivery systems, Expet Opin Drug Deliv, 13, 547, 10.1517/17425247.2016.1134486

Elbakry, 2009, Layer-by-layer assembled gold nanoparticles for siRNA delivery, Nano Lett, 9, 2059, 10.1021/nl9003865

Lee, 2011, Effective gene silencing by multilayered siRNA-coated gold nanoparticles, Small, 7, 364, 10.1002/smll.201001314

Lee, 2011, Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex, ACS Nano, 5, 6138, 10.1021/nn2017793

Jhaveri, 2014, Multifunctional polymeric micelles for delivery of drugs and siRNA, Front Pharmacol, 5, 1, 10.3389/fphar.2014.00077

Falamarzian, 2012, Polymeric micelles for siRNA delivery, J Drug Deliv Sci Technol, 43–54

Fernandez, 2001, N-Succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity, J Med Chem, 44, 3750, 10.1021/jm0108754

Lu, 2013, Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs, Int J Pharm, 453, 198, 10.1016/j.ijpharm.2012.08.042

Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J Control Release, 65, 271, 10.1016/S0168-3659(99)00248-5

Kedar, 2010, Advances in polymeric micelles for drug delivery and tumor targeting, Nanomed Nanotechnol Biol Med, 6, 714, 10.1016/j.nano.2010.05.005

Iyer, 2006, Exploiting the enhanced permeability and retention effect for tumor targeting, Drug Discov Today, 11, 812, 10.1016/j.drudis.2006.07.005

Hobbs, 1998, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc Natl Acad Sci U S A, 95, 4607, 10.1073/pnas.95.8.4607

Xu, 2015, Cancer nanomedicine: from targeted delivery to combination therapy, Trends Mol Med, 21, 223, 10.1016/j.molmed.2015.01.001

Danhier, 2010, To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery, J Control Release, 148, 135, 10.1016/j.jconrel.2010.08.027

Kirpotin, 2006, Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models, Canc Res, 66, 6732, 10.1158/0008-5472.CAN-05-4199

Jin, 2010, Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')2 for hepatocellular carcinoma, Biomacromolecules, 11, 2422, 10.1021/bm1005992

Cheng, 2013, Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery, Biomaterials, 34, 3647, 10.1016/j.biomaterials.2013.01.084

Liberti, 2016, The Warburg effect: how does it benefit cancer cells?, Trends Biochem Sci, 41, 211, 10.1016/j.tibs.2015.12.001

Gerweck, 1996, Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer, Canc Res, 56, 1194

Yoshida, 2013, PH-and ion-sensitive polymers for drug delivery, Expet Opin Drug Deliv, 10, 1497, 10.1517/17425247.2013.821978

Jiang, 2016, Magnetic Hydrogels from alkyne/cobalt carbonyl-functionalized ABA triblock copolymers, J Am Chem Soc, 138, 4616, 10.1021/jacs.6b01271

Panja, 2016, Tailor-made temperature-sensitive micelle for targeted and on-demand release of anticancer drugs, ACS Appl Mater Interfaces, 8, 12063, 10.1021/acsami.6b03820

Blanco, 2009, Multifunctional micellar nanomedicine for cancer therapy, Exp Biol Med, 234, 123, 10.3181/0808-MR-250

Duong, 2013, Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment, Int J Pharm, 454, 486, 10.1016/j.ijpharm.2013.06.017

Christie, 2012, Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection, ACS Nano, 6, 5174, 10.1021/nn300942b

Lu, 2019, Erratum: highly efficient gene release in spatiotemporal precision approached by light and pH dual responsive copolymers, Chem Sci, 10, 284, 10.1039/C8SC01494A

Hao, 2019, Targeted co-delivery of siRNA and methotrexate for tumor therapy via mixed micelles, Pharmaceutics, 11, 1, 10.3390/pharmaceutics11020092

Hazekawa, 2019, Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination model, J Pharmacol Sci, 139, 231, 10.1016/j.jphs.2019.01.009

Hao, 2019, Targeted and efficient delivery of siRNA using tunable polymeric hybrid micelles for tumor therapy, Anticancer Res, 39, 1169, 10.21873/anticanres.13226

Xu, 2019, Facile hydrophobization of siRNA with anticancer drug for non-cationic nanocarrier-mediated systemic delivery, Nano Lett, 19, 2688, 10.1021/acs.nanolett.9b00657

Wang, 2019, Targeting EZH2 for glioma therapy with a novel nanoparticle‒siRNA complex, Int J Nanomed, 14, 2637, 10.2147/IJN.S189871

Li, 2019, Dual-blockade immune checkpoint for breast cancer treatment based on a tumor-penetrating peptide assembling nanoparticle, ACS Appl Mater Interfaces, 11, 39513, 10.1021/acsami.9b13354

Yang, 2018, Sequential delivery of VEGF siRNA and paclitaxel for PVN destruction, anti-angiogenesis, and tumor cell apoptosis procedurally via a multi-functional polymer micelle, J Control Release, 287, 103, 10.1016/j.jconrel.2018.08.028

Suo, 2017, Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA, Mater Sci Eng C, 76, 659, 10.1016/j.msec.2017.03.124

Lee, 2016, A theranostic micelleplex co-delivering Sn-38 and VEGF siRNA for colorectal cancer therapy, Biomaterials, 86, 92, 10.1016/j.biomaterials.2016.01.068

Kanazawa, 2012, Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles, Eur J Pharm Biopharm, 81, 470, 10.1016/j.ejpb.2012.04.021

Wu, 2016, Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles, Colloids Surf B Biointerfaces, 138, 60, 10.1016/j.colsurfb.2015.11.041

Fang, 2014, ZEB1 knockdown mediated using polypeptide cationic micelles inhibits metastasis and effects sensitization to a chemotherapeutic drug for cancer therapy, Nanoscale, 6, 10084, 10.1039/C4NR01518E

Xiong, 2011, Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin, ACS Nano, 5, 5202, 10.1021/nn2013707

Yu, 2013, Macrophage-specific RNA interference targeting via “click”, mannosylated polymeric micelles, Mol Pharm, 10, 975, 10.1021/mp300434e

Li, 2013, Green synthetic, multifunctional hybrid micelles with shell embedded magnetic nanoparticles for theranostic applications, ACS Appl Mater Interfaces, 5, 7227, 10.1021/am401573b

Song, 2013, Construction of targeting-clickable and tumor-cleavable polyurethane nanomicelles for multifunctional intracellular drug delivery, Biomacromolecules, 14, 4407, 10.1021/bm401342t

Ding, 2013, Toward the next-generation nanomedicines: design of multifunctional multiblock polyurethanes for effective cancer treatment, ACS Nano, 7, 1918, 10.1021/nn4002769

Zhu, 2013, Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety, Proc Natl Acad Sci U S A, 110, 17047, 10.1073/pnas.1304987110

Tang, 2019, PD-L1 knockdown via hybrid micelle promotes paclitaxel induced cancer-immunity cycle for melanoma treatment, Eur J Pharmaceut Sci, 127, 161, 10.1016/j.ejps.2018.10.021

Pan, 2019, Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance, Eur J Pharm Biopharm, 136, 18, 10.1016/j.ejpb.2019.01.006

Kim, 2008, Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer, J Control Release, 129, 107, 10.1016/j.jconrel.2008.03.008

Decuzzi, 2008, The receptor-mediated endocytosis of nonspherical particles, Biophys J, 94, 3790, 10.1529/biophysj.107.120238

Xiong, 2010, Virus-mimetic polymeric micelles for targeted siRNA delivery, Biomaterials, 31, 5886, 10.1016/j.biomaterials.2010.03.075

Rabideau, 2016, Delivery of non-native cargo into mammalian cells using anthrax lethal toxin, ACS Chem Biol, 11, 1490, 10.1021/acschembio.6b00169

Cheng, 2018, Protein nanotherapeutics as an emerging modality for cancer therapy, Adv Healthc Mater, 7, 1, 10.1002/adhm.201800685

Liu, 2019, Recent advances in anti-cancer protein/peptide delivery, Bioconjugate Chem, 30, 305, 10.1021/acs.bioconjchem.8b00750

Stewart, 2018, Intracellular delivery by membrane disruption: mechanisms, strategies, and concepts, Chem Rev, 118, 7409, 10.1021/acs.chemrev.7b00678

Yang, 2015, Surface-engineered dendrimers in gene delivery, Chem Rev, 115, 5274, 10.1021/cr500542t

Wang, 2018, A Self-assembled coumarin-anchored dendrimer for efficient gene delivery and light-responsive drug delivery, Biomacromolecules, 19, 2194, 10.1021/acs.biomac.8b00246

Liu, 2016, Screening of efficient siRNA carriers in a library of surface-engineered dendrimers, Sci Rep, 6, 1

Yang, 2013, A nanoparticle formulation that selectively transfects metastatic tumors in mice, Proc Natl Acad Sci U S A, 110, 14717, 10.1073/pnas.1313330110

Hashim, 2015, Reductively cleavable nanocaplets for siRNA delivery by template-assisted oxidative polymerization, J Am Chem Soc, 137, 15608, 10.1021/jacs.5b08948

Yang, 2012, Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery, ACS Nano, 6, 771, 10.1021/nn204240b

Bakker, 2016, Multicomponent supramolecular polymers as a modular platform for intracellular delivery, ACS Nano, 10, 1845, 10.1021/acsnano.5b05383

Juanes, 2019, Messenger RNA delivery by hydrazone-activated polymers, MedChemComm, 10, 1138, 10.1039/C9MD00231F

Spagnou, 2004, Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA, Biochemistry, 43, 13348, 10.1021/bi048950a

Moghimi, 2005, A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy, Mol Ther, 11, 990, 10.1016/j.ymthe.2005.02.010

Namgung, 2009, Synergistic effect of low cytotoxic linear polyethylenimine and multiarm polyethylene glycol: study of physicochemical properties and in vitro gene transfection, Mol Pharm, 6, 1826, 10.1021/mp900096u

Mao, 2006, Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes, Bioconjugate Chem, 17, 1209, 10.1021/bc060129j

Park, 2010, pH-responsive polymers as gene carriers, Macromol Rapid Commun, 31, 1122, 10.1002/marc.200900867

De las Heras Alarcón, 2005, Stimuli responsive polymers for biomedical applications, Chem Soc Rev, 34, 276, 10.1039/B406727D

Oskuee, 2010, The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery, J Gene Med, 12, 729, 10.1002/jgm.1490

Hunter, 2002, Therapeutic synthetic polymers: a game of Russian roulette?, Drug Discov Today, 7, 998, 10.1016/S1359-6446(02)02444-3

Philipp, 2009, Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery, Bioconjugate Chem, 20, 2055, 10.1021/bc9001536

Kim, 2010, A guanidinylated bioreducible polymer with high nuclear localization ability for gene delivery systems, Biomaterials, 31, 1798, 10.1016/j.biomaterials.2009.10.034

Son, 2010, Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier, Biomaterials, 31, 6344, 10.1016/j.biomaterials.2010.04.047

Son, 2011, RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain, J Control Release, 155, 18, 10.1016/j.jconrel.2010.08.011

Singha, 2011, Polymers in small-interfering RNA delivery, Nucleic Acid Therapeut, 21, 133, 10.1089/nat.2011.0293

Kim, 2007, Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy, J Control Release, 118, 357, 10.1016/j.jconrel.2006.12.026

Biswal, 2010, Development of a targeted siRNA delivery system using FOL‒PEG‒PEI conjugate, Mol Biol Rep, 37, 2919, 10.1007/s11033-009-9853-3

Yamaoka, 1993, Body distribution profile of polysaccharides after intravenous administration, Drug Deliv, 1, 75, 10.3109/10717549309031345

Park, 2003, Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier: preparation and physicochemical characterization of GC‒graft‒PVP/DNA complex (1), J Control Release, 86, 349, 10.1016/S0168-3659(02)00365-6

Kim, 2010, Galactosylated cucurbituril-inclusion polyplex for hepatocyte-targeted gene delivery, Chem Commun, 46, 692, 10.1039/B920753H

Lee, 2010, Pluronic/polyethylenimine shell crosslinked nanocapsules with embedded magnetite nanocrystals for magnetically triggered delivery of siRNA, Macromol Biosci, 10, 239, 10.1002/mabi.200900291

Yuan, 2006, siRNA drug delivery by biodegradable polymeric nanoparticles, J Nanosci Nanotechnol, 6, 2821, 10.1166/jnn.2006.436

Son, 2010, Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery, Biomaterials, 31, 133, 10.1016/j.biomaterials.2009.09.024

Tahara, 2008, Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery, Int J Pharm, 354, 210, 10.1016/j.ijpharm.2007.11.002

Cun, 2010, Preparation and characterization of poly(d,l-lactide-co-glycolide) nanoparticles for siRNA delivery, Int J Pharm, 390, 70, 10.1016/j.ijpharm.2009.10.023

Cun, 2011, High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization, Eur J Pharm Biopharm, 77, 26, 10.1016/j.ejpb.2010.11.008

Wang, 2010, Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment, Int J Pharm, 400, 194, 10.1016/j.ijpharm.2010.08.026

Hombach, 2009, Chitosan solutions and particles: evaluation of their permeation enhancing potential on MDCK cells used as blood brain barrier model, Int J Pharm, 376, 104, 10.1016/j.ijpharm.2009.04.027

Andersen, 2010, Surface functionalisation of PLGA nanoparticles for gene silencing, Biomaterials, 31, 5671, 10.1016/j.biomaterials.2010.03.069

Alshamsan, 2010, STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response, Mol Pharm, 7, 1643, 10.1021/mp100067u

Oster, 2005, Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques, J Microencapsul, 22, 235, 10.1080/02652040500100295

Katas, 2009, Preparation of polyethyleneimine incorporated poly(d,l-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery, Int J Pharm, 369, 144, 10.1016/j.ijpharm.2008.10.012

Risnayanti, 2018, PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer, Sci Rep, 8, 1, 10.1038/s41598-018-25930-7

Patil, 2009, Polymeric nanoparticles for siRNA delivery and gene silencing, Int J Pharm, 367, 195, 10.1016/j.ijpharm.2008.09.039

Hasan, 2012, Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer, Nano Lett, 12, 287, 10.1021/nl2035354

Wang, 2017, Synthesis of PLGA–lipid hybrid nanoparticles for siRNA delivery using the emulsion method PLGA‒PEG–lipid nanoparticles for siRNA delivery, Methods Mol Biol, 1632, 231, 10.1007/978-1-4939-7138-1_15

Mao, 2010, Chitosan-based formulations for delivery of DNA and siRNA, Adv Drug Deliv Rev, 62, 12, 10.1016/j.addr.2009.08.004

Opanasopit, 2010, Nucleic acid delivery with chitosan hydroxybenzotriazole, Oligonucleotides, 20, 127, 10.1089/oli.2009.0227

Rojanarata, 2008, Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery, Pharm Res, 25, 2807, 10.1007/s11095-008-9648-6

Roy, 2008, Enhancing polysaccharide-mediated delivery of nucleic acids through functionalization with secondary and tertiary amines, Curr Top Med Chem, 8, 331, 10.2174/156802608783790947

Howard, 2006, RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system, Mol Ther, 14, 476, 10.1016/j.ymthe.2006.04.010

Choi, 2015, Glutamine-chitosan modified calcium phosphate nanoparticles for efficient siRNA delivery and osteogenic differentiation, J Mater Chem B, 3, 6448, 10.1039/C5TB00843C

Ni, 2017, Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation, J Drug Target, 25, 451, 10.1080/1061186X.2016.1278219

Sun, 2016, Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis, Int J Nanomed, 11, 4931, 10.2147/IJN.S105427

Shahana, 2002, Effects of the cationic protein poly-l-arginine on airway epithelial cells in vitro, Mediat Inflamm, 11, 141, 10.1080/09622935020138172

Noh, 2010, Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA, J Control Release, 145, 159, 10.1016/j.jconrel.2010.04.005

Kim, 2009, Hyaluronic acid complexed to biodegradable poly l-arginine for targeted delivery of siRNAs, J Gene Med, 11, 791, 10.1002/jgm.1352

Plianwong, 2013, Chitosan combined with poly-l-arginine as efficient, safe, and serum-insensitive vehicle with RNase protection ability for siRNA delivery, BioMed Res Int, 2013, 1, 10.1155/2013/574136

Wan, 2015, Novel hydroxybutyl chitosan nanoparticles for siRNA delivery targeting tissue factor inhibits proliferation and induces apoptosis in human vascular smooth muscle cells, Mol Med Rep, 12, 7957, 10.3892/mmr.2015.4461

Arami, 2017, Synthesis and characterization of Fe3O4-PEG-LAC-chitosan-PEI nanoparticle as a survivin siRNA delivery system, Hum Exp Toxicol, 36, 227, 10.1177/0960327116646618

Shen, 2020, Natural polyphenol inspired polycatechols for efficient siRNA delivery, CCS Chem, 2, 146, 10.31635/ccschem.020.201900084

Chung, 2014, Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy, Nat Nanotechnol, 9, 907, 10.1038/nnano.2014.208

Shen, 2018, Green tea catechin dramatically promotes RNAi mediated by low-molecular-weight polymers, ACS Cent Sci, 4, 1326, 10.1021/acscentsci.8b00363

Hassler, 2018, Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo, Nucleic Acids Res, 46, 2185, 10.1093/nar/gky037

Mansoori, 2016, Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA). Artif Cells, Nanomedicine Biotechnol, 44, 1589

Huntzinger, 2011, Gene silencing by microRNAs: contributions of translational repression and mRNA decay, Nat Rev Genet, 12, 99, 10.1038/nrg2936

Deleavey, 2009, Chemical modification of siRNA, Current Protocols in Nucleic Acid Chemistry, 39, 1, 10.1002/0471142700.nc1603s39

Allerson, 2005, Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA, J Med Chem, 48, 901, 10.1021/jm049167j

Shan, 2008, A small molecule enhances RNA interference and promotes microRNA processing, Nat Biotechnol, 26, 933, 10.1038/nbt.1481

Diebold, 2006, Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides, Eur J Immunol, 36, 3256, 10.1002/eji.200636617

Wei, 2020, Ultrasound-responsive polymersomes capable of endosomal escape for efficient cancer therapy, J Control Release, 322, 81, 10.1016/j.jconrel.2020.03.013

Puri, 2020, Photoactivation of sulfonated polyplexes enables localized gene silencing by DsiRNA in breast cancer cells, Nanomed Nanotechnol Biol Med, 26, 102176, 10.1016/j.nano.2020.102176

Song, 2005, Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors, Nat Biotechnol, 23, 709, 10.1038/nbt1101

Sarett, 2017, Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing, Proc Natl Acad Sci U S A, 114, E6490, 10.1073/pnas.1621240114

Sato, 2016, Development of a multifunctional envelope-type nano device and its application to nanomedicine, J Control Release, 244, 194, 10.1016/j.jconrel.2016.06.042

Khalil, 2007, Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery, Gene Ther, 14, 682, 10.1038/sj.gt.3302910

Moriguchi, 2005, A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids, Int J Pharm, 301, 277, 10.1016/j.ijpharm.2005.05.021

Kortylewski, 2009, in vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses, Nat Biotechnol, 27, 925, 10.1038/nbt.1564

Khalil, 2018, Synergism between a cell penetrating peptide and a pH-sensitive cationic lipid in efficient gene delivery based on double-coated nanoparticles, J Control Release, 275, 107, 10.1016/j.jconrel.2018.02.016

Rungta, 2013, Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain, Mol Ther Nucleic Acids, 2, 10.1038/mtna.2013.65

Chaudhary, 2017, siRNA delivery using polyelectrolyte-gold nanoassemblies in neuronal cells for BACE1 gene silencing, Mater Sci Eng C, 80, 18, 10.1016/j.msec.2017.05.101

Solanki, 2013, Nanotopography-mediated reverse uptake for siRNA delivery into neural stem cells to enhance neuronal differentiation, Sci Rep, 3, 1, 10.1038/srep01553

Kumar, 2007, Transvascular delivery of small interfering RNA to the central nervous system, Nature, 448, 39, 10.1038/nature05901

Huwyler, 2008, Tumor targeting using liposomal antineoplastic drugs, Int J Nanomed, 3, 21, 10.2147/IJN.S1253

Dokka, 2000, Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes, Pharm Res, 17, 521, 10.1023/A:1007504613351

Akhtar, 2007, Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity, Adv Drug Deliv Rev, 59, 164, 10.1016/j.addr.2007.03.010

Filion, 1998, Major limitations in the use of cationic liposomes for DNA delivery, Int J Pharm, 162, 159, 10.1016/S0378-5173(97)00423-7

Sharma, 2012, Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems, Expet Opin Drug Metabol Toxicol, 8, 47, 10.1517/17425255.2012.637916